Sabina Signoretti

32PUBLICATIONS
327CO-AUTHORS
Molecular targetsSolid tumoursComputational imagingInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 24, 2026
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma.

|Jul 22, 2026
Tertiary lymphoid structures harbour stem-like tumour-specific T cells.

|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial.

|Mar 24, 2026
Same-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo

|Nov 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs.

Treg Grubb, Pooneh Koochaki, Sayed Matar

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

Pageof 6

Frequent Collaborators

16 joint publications

Toni K Choueiri

10 joint publications

David Braun

9 joint publications

Thomas Denize

7 joint publications

Michael B Atkins